Disulfide and amide-bridged cyclic peptide analogues of the VEGF₈₁₋₉₁ fragment: synthesis, conformational analysis and biological evaluation

Bioorg Med Chem. 2011 Dec 15;19(24):7526-33. doi: 10.1016/j.bmc.2011.10.032. Epub 2011 Oct 18.

Abstract

The design, synthesis, conformational studies and binding affinity for VEGFR-1 receptors of a collection of linear and cyclic peptide analogues of the β-hairpin fragment VEGF(81-91) are described. Cyclic 11-mer peptide derivatives were prepared from linear precursors with conveniently located Cys, Asp or Dap residues, by the formation of disulfide and amide bridges, using solid-phase synthesis. Molecular modelling studies indicated a tendency to be structured around the central β-turn of the VEGF(81-91) β-hairpin in most synthesized cyclic compounds. This structural behavior was confirmed by NMR conformational analysis. The NHCO cyclic derivative 7 showed significant affinity for VEGFR-1, slightly higher than the native linear fragment, thus supporting the design of mimics of this fragment as a valid approach to disrupt the VEGF/VEGFR-1 interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / chemistry
  • Amino Acid Sequence
  • Angiogenesis Inhibitors / chemical synthesis
  • Angiogenesis Inhibitors / chemistry
  • Angiogenesis Inhibitors / pharmacology
  • Disulfides / chemistry
  • Humans
  • Models, Molecular
  • Molecular Sequence Data
  • Peptide Fragments / chemical synthesis
  • Peptide Fragments / chemistry*
  • Peptide Fragments / pharmacology*
  • Peptides, Cyclic / chemical synthesis
  • Peptides, Cyclic / chemistry*
  • Peptides, Cyclic / pharmacology*
  • Protein Binding
  • Protein Conformation
  • Solid-Phase Synthesis Techniques
  • Vascular Endothelial Growth Factor A / chemistry*
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism*

Substances

  • Amides
  • Angiogenesis Inhibitors
  • Disulfides
  • Peptide Fragments
  • Peptides, Cyclic
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-1